Info

Mitotix, Incorporated is a biotechnology company engaged in the discovery and development of products to diagnose and treat cancer, opportunistic infections, and other cell proliferation disorders. The company's development programs are based on proprietary and patentable knowledge of the molecular pathways that regulate the cycle of cell growth and division. Mitotix recently formed major corporate collaborations in cancer therapeutics with The DuPont Merck Pharmaceutical Company focused on cyclin-dependent kinase inhibitors and with BASF Pharma focused on cdc25 inhibitors. Mitotix was founded in 1992 and is headquartered in Cambridge, Massachusetts.